Portal de Periódicos da CAPES

Is Amiodarone an Ideal Antiarrhythmic Drug?

1984; Wiley; Volume: 7; Issue: 2 Linguagem: Inglês

10.1111/j.1540-8159.1984.tb04897.x

1540-8159

Mauricio B. Rosenbaum, Pablo A. Chiale, Juan Carlos Kaski, Marcelo V. Elizari,

ECG Monitoring and Analysis

Pacing and Clinical ElectrophysiologyVolume 7, Issue 2 p. 272-275 Is Amiodarone an Ideal Antiarrhythmic Drug? MAURICIO B. ROSENBAUM, Corresponding Author MAURICIO B. ROSENBAUM Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaAddress for reprints: Mauricio B. Rosenbaum, M.D., Chief, Service of Cardiology, Ramos Mejia Hospital, Urquiza 609, Buenos Aires, Argentina.Search for more papers by this authorPABLO A. CHIALE, PABLO A. CHIALE Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaSearch for more papers by this authorJUAN C. KASKI, JUAN C. KASKI Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaSearch for more papers by this authorMARCELO V. ELIZARI, MARCELO V. ELIZARI Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaSearch for more papers by this author MAURICIO B. ROSENBAUM, Corresponding Author MAURICIO B. ROSENBAUM Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaAddress for reprints: Mauricio B. Rosenbaum, M.D., Chief, Service of Cardiology, Ramos Mejia Hospital, Urquiza 609, Buenos Aires, Argentina.Search for more papers by this authorPABLO A. CHIALE, PABLO A. CHIALE Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaSearch for more papers by this authorJUAN C. KASKI, JUAN C. KASKI Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaSearch for more papers by this authorMARCELO V. ELIZARI, MARCELO V. ELIZARI Service of Cardiology, Ramos Mejía Hospital, Buenos Aires, ArgentinaSearch for more papers by this author First published: March 1984 https://doi.org/10.1111/j.1540-8159.1984.tb04897.xCitations: 7 This work was supported in part by the Fundación de Investigaciones Cardiológicas Einthoven and the Comisión para el Estudio Integral de la Enfermedad de Chagas. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rosenbaum, M.B., Chiale, P.A., Halpern, M.S., et al.: Clinical efficacy of amiodarone as an antiarrhythmic agent. Am. J. Cardiol., 38: 934, 1976. 2 Leak, D., Eydt, J.N.: Control of refractory cardiac arrhythmias with amiodarone. Arch. Int. Med., 139: 425, 1979. 3 Wheeler, P.J., Puritz, R., Ingram, D.V., et al.: Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias. Postgrad. Med. J., 55: 1, 1979. 4 Rakita, L., McGee, J., Sobol, S., et al.: Clinical trial of amiodarone hydrochloride for the treatment of refractory arrhythmia. Am. J. Cardiol., 43: 359, 1979. 5 Rowland, E., Krikler, D.M.: Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br. Heart J., 44: 82, 1980. 6 Ward, D.E., Camm, A.J., Spurrell, R.A.J.: Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias. Br. Heart J., 44: 91, 1980. 7 Singh, B.N., Collett, J.T., Chew, C.Y.C.: New perspectives in the pharmacological control of cardiac arrhythmias. Progr. Cardiovasc. Dis., 22: 243, 1980. 8 Kaski, J.C., Girotti, L.A., Messuti, H., et al: Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation, 64: 273, 1981. 9 Heger, J.J., Prystowsky, E.N., Jackman, W.M., et al.: Amiodarone. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N. Engl. J. Med., 305: 539, 1981. 10 Nademanee, K., Hendrickson, J.A., Cannom, D.S., et al.: Control of refractory life-threatening ventricular arrhythmias by amiodarone. Am. Heart J., 101: 759, 1981. 11 Hamer, A.W., Finerman, W.B., Peter, T., et al: Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias. Am. Heart J., 102: 992, 1981. 12 Marcus, F.I., Fontaine, G.H., Frank, R., et al.: Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone. Am. Heart J., 101: 480, 1981. 13 Podrid, P.J., Lown, B.: Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. Am. Heart J., 101: 374, 1981. 14 Nademanee, K., Hendrickson, J.A., Kannan, R., et al.: Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: Potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia. Am. Heart J., 103: 950, 1982. 15 Kaski, J.C., Girotti, L.A., Elizari, M.V., et al.: Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias. In patients with chronic stable ischemic heart disease. Am. Heart J. (in press, 1983). 16 Chiale, P.A., Halpern, M.S., Nau, G.J., et al.: Malignant ventricular arrhythmias in chronic chagasic myocarditis. PACE, 5: 162, 1982. 17 Chiale, P.A., Halpern, M.S., Nau, G.J., et al.: Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. Am. Heart J. (in press, 1983). 18 Rosenbaum, M.B., Chiale, P.A., Ryba, D., et al.: Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am. J. Cardiol., 34: 215, 1974. 19 Broeckhyysen, J., Laruel, R., Sion, R.: Recherches dans la série des benzofurannes. XXXVII. Étude comparée du transit et du métabolisme de l'amiodarone chez diverses és±eces animales et chez l'homme. Arch. Int. Pharmacodyn. Ther., 177: 340, 1969. 20 Rosenbaum, M.B., Davidenko, J.M., Vetulli, H.M., et al.: Antiarrhythmic drugs with cumulative effects. In Symposium on Antiarrhythmic and Antianginal Drugs with Cumulative Effects, Paris , Laboratoires Labaz, 1980, p. 35. 21 Nademanee, K., Singh, B.N., Hendrickson, J.A., et al.: Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: A potential method for monitoring chronic drug therapy. Circulation, 66: 202, 1982. 22 Chiale, P.A., Halpern, M.S., Nau, G.J., et al.: Drogas antiarrítmicas de fuerte efecto acumulativo en la prevención de la muerte súbita. Rev. Latina Cardiol., 1: 26, 1980. 23 Rosenbaum, M.B., Chiale, P.A., Halpern, M.S., et al.: Amiodarone: A new antiarrhythmic drug With strong cumulative effect. In Selected Topics in Cardiac Arrhythmias, Futura Publishing Co., 1980, p. 143. 24 Sobol, S.M., Rakita, L.: Pheumonitis and pulmonary fibrosis associated with amiodarone treatment: A possible complication of a new antiarrhythmic drug. Circulation, 65: 819, 1982. 25 Harris, L., McKenna, W.J., Rowland, E., et al.: Amiodarone: Side effects of long-term therapy. Circulation (in press, 1983). 26 Dreifus, L.S., Ogawa, S.: Quality of the ideal antiarrhythmic drug. Am. J. Cardiol., 39: 466, 1977. Citing Literature Volume7, Issue2March 1984Pages 272-275 ReferencesRelatedInformation